(VIANEWS) – ProLogis (PLD), First Hawaiian (FHB), Burlington Stores (BURL) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. ProLogis (PLD)
55.3% sales growth and 7.44% return on equity
Prologis, Inc. is the global leader in logistics real estate with a focus on high-barrier, high-growth markets. As of December 31, 2020, the company owned or had investments in, on a wholly owned basis or through co-investment ventures, properties and development projects expected to total approximately 984 million square feet (91 million square meters) in 19 countries. Prologis leases modern logistics facilities to a diverse base of approximately 5,500 customers principally across two major categories: business-to-business and retail/online fulfillment.
Earnings Per Share
As for profitability, ProLogis has a trailing twelve months EPS of $4.25.
PE Ratio
ProLogis has a trailing twelve months price to earnings ratio of 28.87. Meaning, the purchaser of the share is investing $28.87 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 7.44%.
Dividend Yield
According to Morningstar, Inc., the next dividend payment is on Mar 15, 2023, the estimated forward annual dividend rate is 3.48 and the estimated forward annual dividend yield is 2.91%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 25.6%, now sitting on 6.28B for the twelve trailing months.
Sales Growth
ProLogis’s sales growth is 50.8% for the current quarter and 55.3% for the next.
2. First Hawaiian (FHB)
17% sales growth and 10.79% return on equity
First Hawaiian, Inc. operates as a bank holding company for First Hawaiian Bank that provides a range of banking services to consumer and commercial customers in the United States. It operates in three segments: Retail Banking, Commercial Banking, and Treasury and Other. The company accepts various deposit products, including checking and savings accounts, and time deposit accounts. It also provides residential and commercial mortgage loans, home equity lines of credit, automobile loans and leases, personal lines of credit, installment loans, and small business loans and leases, commercial lease financing, and auto dealer financing. In addition, the company offers personal installment, credit card, individual investment and financial planning, insurance protection, trust and estate, private banking, retirement planning, treasury, and merchant processing services. As of December 31, 2020, it operated 54 branches in Oahu, Maui, Hawaii, Kauai, Lanai, Guam, and Saipan. The company was formerly known as BancWest Corporation and changed its name to First Hawaiian, Inc. in April 2016. The company was founded in 1858 and is headquartered in Honolulu, Hawaii. First Hawaiian, Inc. is a subsidiary of BancWest Corporation.
Earnings Per Share
As for profitability, First Hawaiian has a trailing twelve months EPS of $2.08.
PE Ratio
First Hawaiian has a trailing twelve months price to earnings ratio of 9.72. Meaning, the purchaser of the share is investing $9.72 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.79%.
Sales Growth
First Hawaiian’s sales growth is 42.3% for the current quarter and 17% for the next.
3. Burlington Stores (BURL)
11.6% sales growth and 29.59% return on equity
Burlington Stores, Inc. operates as a retailer of branded apparel products in the United States. The company provides fashion-focused merchandise, including women's ready-to-wear apparel, menswear, youth apparel, footwear, accessories, toys, gifts, and coats, as well as baby, home, and beauty products. It operates stores under the Burlington Stores, and Cohoes Fashions brand names in Puerto Rico. Burlington Stores, Inc. was founded in 1972 and is headquartered in Burlington, New Jersey.
Earnings Per Share
As for profitability, Burlington Stores has a trailing twelve months EPS of $3.51.
PE Ratio
Burlington Stores has a trailing twelve months price to earnings ratio of 53.49. Meaning, the purchaser of the share is investing $53.49 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 29.59%.
4. Itau Unibanco (ITUB)
7.1% sales growth and 58.09% return on equity
Itaú Unibanco Holding S.A. offers a range of financial products and services to individuals and corporate customers in Brazil and internationally. The company operates through three segments: Retail Banking, Wholesale Banking, and Activities with the Market + Corporation. It offers current account; loans; credit and debit cards; investment and commercial banking services; real estate lending services; financing and investment services; economic, financial and brokerage advisory; and leasing and foreign exchange services. The company also provides property and casualty insurance products covering loss, damage, or liabilities for assets or persons, as well as life insurance products covering death and personal accident. It serves retail customers, account and non-account holders, individuals and legal entities, high income clients, microenterprises, and small companies. The company was formerly known as Itaú Unibanco Banco Múltiplo S.A. and changed its name to Itaú Unibanco Holding S.A. in April 2009. The company was incorporated in 1924 and is headquartered in São Paulo, Brazil. Itaú Unibanco Holding S.A. is a subsidiary of IUPAR – Itaú Unibanco Participações S.A.
Earnings Per Share
As for profitability, Itau Unibanco has a trailing twelve months EPS of $0.61.
PE Ratio
Itau Unibanco has a trailing twelve months price to earnings ratio of 8.55. Meaning, the purchaser of the share is investing $8.55 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 58.09%.
Sales Growth
Itau Unibanco’s sales growth is 12% for the current quarter and 7.1% for the next.
Revenue Growth
Year-on-year quarterly revenue growth grew by 49.4%, now sitting on 171.87B for the twelve trailing months.
5. Ashland (ASH)
6.8% sales growth and 6.28% return on equity
Ashland Global Holdings Inc. provides additives and specialty ingredients worldwide. It operates through Life Sciences; Personal Care & Household; Specialty Additives; and Intermediates and Solvents segments. The Life Sciences segment offers pharmaceutical solutions, including controlled release polymers, disintegrants, tablet coatings, thickeners, solubilizers, and tablet binders; nutrition solutions, such as thickeners, stabilizers, emulsifiers, and additives; and nutraceutical solutions comprising products for weight management, joint comfort, stomach and intestinal health, sports nutrition, and general wellness, as well as custom formulation, toll processing, and particle engineering solutions. The Personal Care & Household segment provides a range of nature-based, biodegradable, and performance ingredients; solutions for toothpastes, mouth washes and rinses, denture cleaning, and care for teeth; and household supplies nature-derived rheology ingredients, biodegradable surface wetting agents, performance encapsulates, and specialty polymers. The Specialty Additives segment offers rheology modifiers, foam control agents, surfactants and wetting agents, pH neutralizers, advanced ceramics used in catalytic converters, environmental filters, ingredients for the manufacturing of ceramic capacitors, plasma display panels and solar cells, ingredients for textile printing, thermoplastic metals, and alloys for welding. The Intermediates and Solvents segment produces 1,4 butanediol and related derivatives, including n-methylpyrrolidone. Ashland Global Holdings Inc. offers its products to customers in a range of consumer and industrial markets, such as architectural coatings, construction, energy, food and beverage, nutraceuticals, personal care, and pharmaceutical. The company was formerly known as Ashland Inc. and changed its name to Ashland Global Holdings Inc. in September 2016. Ashland Global Holdings Inc. was founded in 1924 and is based in Wilmington, Delaware.
Earnings Per Share
As for profitability, Ashland has a trailing twelve months EPS of $3.41.
PE Ratio
Ashland has a trailing twelve months price to earnings ratio of 30.2. Meaning, the purchaser of the share is investing $30.2 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 6.28%.
Moving Average
Ashland’s value is higher than its 50-day moving average of $101.77 and under its 200-day moving average of $103.57.
Sales Growth
Ashland’s sales growth is 5.4% for the current quarter and 6.8% for the next.
6. Globus Medical (GMED)
6.6% sales growth and 10.6% return on equity
Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. It offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative, deformity, tumors, and trauma conditions; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional pain management solutions to treat vertebral compression fractures; and regenerative biologic products comprising of allografts and synthetic alternatives. The company also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and hip and knee joint solutions, including modular hip stems and acetabular cups, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants. In addition, it distributes human cell, tissue, and cellular and tissue-based products. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.
Earnings Per Share
As for profitability, Globus Medical has a trailing twelve months EPS of $1.88.
PE Ratio
Globus Medical has a trailing twelve months price to earnings ratio of 30.61. Meaning, the purchaser of the share is investing $30.61 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.6%.
Yearly Top and Bottom Value
Globus Medical’s stock is valued at $57.54 at 06:22 EST, way under its 52-week high of $81.78 and way above its 52-week low of $50.92.
Sales Growth
Globus Medical’s sales growth is 10.6% for the ongoing quarter and 6.6% for the next.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Globus Medical’s EBITDA is 105.69.
